CymaBay Therapeutics to Participate in Upcoming Investor Conferences in August and September
NEWARK, Calif., Aug. 14, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (Nasdaq: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today announced that management will participate in upcoming investor conferences, including the Wedbush PacGrow Healthcare Conference, the H.C. Wainwright 20th Annual Global Investment Conference, and the Citi’s 13th Annual Biotech Conference.
|
Wedbush PacGrow Healthcare Conference | |
| Date: | Wednesday, August 15 |
| Time: | 2:30pm Eastern Time |
| Location: | Parker New York, New York, NY |
| Webcast: | http://ir.cymabay.com/events |
| H.C. Wainwright 20th Annual Global Investment Conference | |
| Date: | Wednesday, September 5 |
| Time: | 9:10am Eastern Time |
| Location: | St. Regis Hotel, New York, NY |
| Webcast: | http://ir.cymabay.com/events |
| Citi’s 13th Annual Biotech Conference | |
| Date: | Thursday, September 6 |
| Time: | 1-on-1 meetings only |
| Location: | Four Seasons Hotel, Boston, MA |
About CymaBay
CymaBay Therapeutics, Inc. (CBAY) is a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet medical need. Seladelpar is a potent, selective, orally active PPARδ agonist, currently in development for the treatment of patients with primary biliary cholangitis (PBC), an autoimmune liver disease, and with non-alcoholic steatohepatitis (NASH).
For additional information about CymaBay visit www.cymabay.com.
Contact:
Hans Vitzthum
LifeSci Advisors, LLC
212-915-2568
Hans@LifeSciAdvisors.com
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.
